Lapatinib, trastuzumab or the combination added to preoperative chemotherapy for breast cancer: a meta-analysis of randomized evidence

Overview of attention for article published in Breast Cancer Research and Treatment, August 2012

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age
Average Attention Score compared to outputs of the same age and source

Mentioned by

policy: 1 policy source

Citations

dimensions_citation: 50 Dimensions

Readers on

mendeley: 49 Mendeley

Summary Policy documents Dimensions citations

So far, Dimensions has found 50 publications that cite this research output.

50

The most recent citing publications are shown below. View all 50 publications that cite this research output on Dimensions.

The Management of Metastatic Triple-Negative Breast Cancer: An Integrated and Expeditionary Approach

Monograph (December 2023)

Association of PIK3CA Mutation With Pathologic Complete Response and Outcome by Hormone Receptor Status and Intrinsic Subtype in Early-Stage ERBB2/HER2-Positive Breast Cancer

Article in JAMA Network Open (December 2023)

PTX3 from vascular endothelial cells contributes to trastuzumab-induced cardiac complications

Article in Cardiovascular Research (January 2023)

This page shows the most recent citations of this research output.

Click here to find out how to access more activity.